YAP1 and cancer: Since preclinical studies involving autophagy inhibition [43–45] have motivated a large number of clinical trials targeting autophagy as part of combination therapy treatment of various cancers, this study revealed a clinical opportunity involving the combination of chemo-radiotherapy with pharmacological autophagy inhibition for treating GBM patients with YAP high expression.